Table 1 Clinical characteristics and procedures in glaucoma associated with cosmetic iris implants.
Patient Characteristics | Number of Patients (N = 9), N (%) |
|---|---|
Male, N (%) | 5 (55.5%) |
Race | |
- White, Hispanic, N (%) | 7 (77.8%) |
- White, Non-Hispanic, N (%) | 2 (22.2%) |
Age at iris implant, years mean ± SD; median (range) | 28.3 ± 5.8; 28 (21–40) |
Age at glaucoma-associated iris implant, years mean ± SD; median (range) | 31.8 ± 5.6; 31 (24–42) |
Time between iris implant and glaucoma diagnosis, years mean ± SD; median (range) | 3.7 ± 3.3; 2 (0–9) |
Follow-up time between glaucoma diagnosis and last visit, years mean ± SD; median (range) | 5.6 ± 3.5; 5 (2–12) |
Location of iris implant surgery | |
- India, N (%) | 2 (22.22%) |
- Panama, N (%) | 2 (22.22%) |
- Mexico, N (%) | 1 (11.11%) |
- Colombia, N (%) | 1 (11.11%) |
- Venezuela, N (%) | 1 (11.11%) |
- Unknown, N (%) | 2 (22.22%) |
Type of iris implant surgery | |
-Bright Ocular Iris | 3 (33.33%) |
-Unknown | 6 (66.67%) |
List of Procedures | Number of Eyes (N = 18), N (%) |
Iris implant removal | 16 (88.9%) |
Cataract surgery | 11 (61.1%) |
Primary Glaucoma Treatment | |
Glaucoma Drainage Device (Baerveldt Glaucoma Implantation-350) | 7 (38.9%) |
Glaucoma Drainage Device (Ahmed-FP7) | 5 (27.8%) |
Glaucoma medication only | 4 (22.2%) |
Trabeculectomy | 2 (11.1%) |
Required second glaucoma surgery | |
Glaucoma Drainage Device (Baerveldt Glaucoma Implantation-350) | 4 (22.2%) |
Cyclophotocoagulation | 2 (11.1%) |
First Corneal Transplantation | |
Descemet’s Stripping Endothelial Keratoplasty (DSEK) | 6 (33.3%) |
Penetrating Keratoplasty procedure (PKP) | 2 (11.1%) |
Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) | 1 (5.6%) |
Repeat corneal transplantation | |
Penetrating Keratoplasty procedure (PKP) | 4 (22.2%) |
